Results 191 to 200 of about 861,631 (245)

Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. [PDF]

Biol Blood Marrow Transplant, 2013
Hobo W, Broen K, van der Velden WJ, Greupink-Draaisma A, Adisty N, Wouters Y, Kester M, Fredrix H, Jansen JH, van der Reijden B, Falkenburg JH, de Witte T, Preijers F, Schattenberg T, Feuth T, Blijlevens NM, Schaap N, Dolstra H.   +17 more
europepmc   +1 more source

Editorial: Methods in alloimmunity and transplantation: 2025. [PDF]

Front Immunol
Kauke-Navarro M, Moll G.
europepmc   +1 more source

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease. [PDF]

Front Oncol
Hasegawa Y, Teshima T, Hashimoto D.
europepmc   +1 more source

HapMap scanning of novel human minor histocompatibility antigens.

Blood, 2009
Kamei M, Nannya Y, Torikai H, Kawase T, Taura K, Inamoto Y, Takahashi T, Yazaki M, Morishima S, Tsujimura K, Miyamura K, Ito T, Togari H, Riddell SR, Kodera Y, Morishima Y, Takahashi T, Kuzushima K, Ogawa S, Akatsuka Y.   +19 more
europepmc   +1 more source

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.

Blood, 2013
Veerapathran A, Pidala J, Beato F, Betts B, Kim J, Turner JG, Hellerstein MK, Yu XZ, Janssen W, Anasetti C.   +9 more
europepmc   +1 more source

IL35 Production After Living-donor Renal Transplantation: Relevance to Local, Exosome-mediated, Clinical Tolerance. [PDF]

Transplant Direct
Burlingham WJ, Fechner JH, Jankowska-Gan E, Tripathi S, Schreiber BL, Chandraker A, Kaufman DB, Foley DP.   +7 more
europepmc   +1 more source

HLA incompatibility mitigation strategies in off-the-shelf cancer immunotherapies: clinical implications and a practical framework for strategy selection and combination. [PDF]

Front Immunol
Das R, Askar M.
europepmc   +1 more source

Selection and Characterisation of Minor Histocompatibility Antigen-Specific Regulatory T Cells in Fully HLA-Matched Setting for GVHD Therapy. [PDF]

Eur J Immunol
Pacini CP, Azevedo RI, Ramalhete L, Lainé HAJ, Soares MVD, Lacerda JF.   +5 more
europepmc   +1 more source

Mixed Lymphocyte Reaction: Functional Immune Profiling in Transplantation and Beyond. [PDF]

Diagnostics (Basel)
Galimov N, Asanova A, Altynova S, Bolatov A.   +3 more
europepmc   +1 more source

CLDN18.2 antibody design with protein language models: A deep learning optimization framework. [PDF]

PLoS Comput Biol
Qu T, Yuan L, Cui W, Tang J, Bing Z, Xu X, Duan J, Yang Q, Cai H.   +8 more
europepmc   +1 more source